151 related articles for article (PubMed ID: 17303774)
21. The association of PLA2G2A single nucleotide polymorphisms with type IIa secretory phospholipase A2 level but not its activity in patients with stable coronary heart disease.
Shuvalova YA; Khasanova ZB; Kaminnaya VI; Samoilova EV; Korotaeva AA; Rubanovich AV; Kaminnyi AI
Gene; 2015 Jun; 564(1):29-34. PubMed ID: 25794429
[TBL] [Abstract][Full Text] [Related]
22. Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile.
Hurt-Camejo E; Paredes S; Masana L; Camejo G; Sartipy P; Rosengren B; Pedreno J; Vallve JC; Benito P; Wiklund O
Arthritis Rheum; 2001 Dec; 44(12):2761-7. PubMed ID: 11762936
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin II type 1-receptor antagonism prevents type IIA secretory phospholipase A2-dependent lipid peroxidation.
Luchtefeld M; Bandlow N; Tietge UJ; Grote K; Pfeilschifter J; Kaszkin M; Beck S; Drexler H; Schieffer B
Atherosclerosis; 2007 Sep; 194(1):62-70. PubMed ID: 17069818
[TBL] [Abstract][Full Text] [Related]
24. Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study.
Meuwese MC; Stroes ES; Hazen SL; van Miert JN; Kuivenhoven JA; Schaub RG; Wareham NJ; Luben R; Kastelein JJ; Khaw KT; Boekholdt SM
J Am Coll Cardiol; 2007 Jul; 50(2):159-65. PubMed ID: 17616301
[TBL] [Abstract][Full Text] [Related]
25. Plasma adhesion and inflammation markers: asymmetrical dimethyl-L-arginine and secretory phospholipase A2 concentrations before and after laparoscopic gastric banding in morbidly obese patients.
Konukoglu D; Uzun H; Firtina S; Cigdem Arica P; Kocael A; Taskin M
Obes Surg; 2007 May; 17(5):672-8. PubMed ID: 17658029
[TBL] [Abstract][Full Text] [Related]
26. Statin therapy and secretory phospholipase A₂ in children with heterozygous familial hypercholesterolemia.
Braamskamp MJ; Tsimikas S; Wiegman A; Kastelein JJ; Hutten BA
Atherosclerosis; 2013 Aug; 229(2):404-7. PubMed ID: 23880195
[TBL] [Abstract][Full Text] [Related]
27. Association of biomarkers of lipid modification with functional and morphological indices of coronary stenosis severity in stable coronary artery disease.
Muller O; Ntalianis A; Wijns W; Delrue L; Dierickx K; Auer R; Rodondi N; Mangiacapra F; Trana C; Hamilos M; Valentin E; De Bruyne B; Barbato E; Bartunek J
J Cardiovasc Transl Res; 2013 Aug; 6(4):536-44. PubMed ID: 23670230
[TBL] [Abstract][Full Text] [Related]
28. Lipoprotein-associated phospholipase A2 independently predicts the angiographic diagnosis of coronary artery disease and coronary death.
May HT; Horne BD; Anderson JL; Wolfert RL; Muhlestein JB; Renlund DG; Clarke JL; Kolek MJ; Bair TL; Pearson RR; Sudhir K; Carlquist JF
Am Heart J; 2006 Nov; 152(5):997-1003. PubMed ID: 17070179
[TBL] [Abstract][Full Text] [Related]
29. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
[TBL] [Abstract][Full Text] [Related]
30. Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study.
Holmes MV; Simon T; Exeter HJ; Folkersen L; Asselbergs FW; Guardiola M; Cooper JA; Palmen J; Hubacek JA; Carruthers KF; Horne BD; Brunisholz KD; Mega JL; van Iperen EPA; Li M; Leusink M; Trompet S; Verschuren JJW; Hovingh GK; Dehghan A; Nelson CP; Kotti S; Danchin N; Scholz M; Haase CL; Rothenbacher D; Swerdlow DI; Kuchenbaecker KB; Staines-Urias E; Goel A; van 't Hooft F; Gertow K; de Faire U; Panayiotou AG; Tremoli E; Baldassarre D; Veglia F; Holdt LM; Beutner F; Gansevoort RT; Navis GJ; Mateo Leach I; Breitling LP; Brenner H; Thiery J; Dallmeier D; Franco-Cereceda A; Boer JMA; Stephens JW; Hofker MH; Tedgui A; Hofman A; Uitterlinden AG; Adamkova V; Pitha J; Onland-Moret NC; Cramer MJ; Nathoe HM; Spiering W; Klungel OH; Kumari M; Whincup PH; Morrow DA; Braund PS; Hall AS; Olsson AG; Doevendans PA; Trip MD; Tobin MD; Hamsten A; Watkins H; Koenig W; Nicolaides AN; Teupser D; Day INM; Carlquist JF; Gaunt TR; Ford I; Sattar N; Tsimikas S; Schwartz GG; Lawlor DA; Morris RW; Sandhu MS; Poledne R; Maitland-van der Zee AH; Khaw KT; Keating BJ; van der Harst P; Price JF; Mehta SR; Yusuf S; Witteman JCM; Franco OH; Jukema JW; de Knijff P; Tybjaerg-Hansen A; Rader DJ; Farrall M; Samani NJ; Kivimaki M; Fox KAA; Humphries SE; Anderson JL; Boekholdt SM; Palmer TM; Eriksson P; Paré G; Hingorani AD; Sabatine MS; Mallat Z; Casas JP; Talmud PJ
J Am Coll Cardiol; 2013 Nov; 62(21):1966-1976. PubMed ID: 23916927
[TBL] [Abstract][Full Text] [Related]
31. C-reactive protein, fatal and nonfatal coronary artery disease, stroke, and peripheral artery disease in the prospective EPIC-Norfolk cohort study.
van Wijk DF; Boekholdt SM; Wareham NJ; Ahmadi-Abhari S; Kastelein JJ; Stroes ES; Khaw KT
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2888-94. PubMed ID: 24072695
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of human group II phospholipase A2 by C-reactive protein in vitro.
Vadas P; Stefanski E; Grouix B; Schouten BD; Pruzanski W
J Lipid Mediat Cell Signal; 1995 Mar; 11(2):187-200. PubMed ID: 7780685
[TBL] [Abstract][Full Text] [Related]
33. The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL.
Korotaeva AA; Samoilova EV; Kaminny AI; Pirkova AA; Resink TJ; Erne P; Prokazova NV; Tkachuk VA; Chazov EI
Mol Cell Biochem; 2005 Feb; 270(1-2):107-13. PubMed ID: 15792359
[TBL] [Abstract][Full Text] [Related]
34. Serum secretory phospholipase A2-IIa (sPLA2-IIA) levels in patients surviving acute myocardial infarction.
Xin H; Chen ZY; Lv XB; Liu S; Lian ZX; Cai SL
Eur Rev Med Pharmacol Sci; 2013 Apr; 17(8):999-1004. PubMed ID: 23661511
[TBL] [Abstract][Full Text] [Related]
35. Secretory type II phospholipase A2 is produced and secreted by epicardial adipose tissue and overexpressed in patients with coronary artery disease.
Dutour A; Achard V; Sell H; Naour N; Collart F; Gaborit B; Silaghi A; Eckel J; Alessi MC; Henegar C; Clément K
J Clin Endocrinol Metab; 2010 Feb; 95(2):963-7. PubMed ID: 20008021
[TBL] [Abstract][Full Text] [Related]
36. Association between serum secretory phospholipase A2 and risk of ischaemic stroke.
Smith JW; Barlas RS; Mamas MA; Boekholdt SM; Mallat Z; Luben RN; Wareham NJ; Khaw KT; Myint PK
Eur J Neurol; 2021 Nov; 28(11):3650-3655. PubMed ID: 34216520
[TBL] [Abstract][Full Text] [Related]
37. A prospective evaluation of lipoprotein-associated phospholipase A(2) levels and the risk of future cardiovascular events in women.
Blake GJ; Dada N; Fox JC; Manson JE; Ridker PM
J Am Coll Cardiol; 2001 Nov; 38(5):1302-6. PubMed ID: 11691499
[TBL] [Abstract][Full Text] [Related]
38. Elevated Type II Secretory Phospholipase A2 Increases the Risk of Early Atherosclerosis in Patients with Newly Diagnosed Metabolic Syndrome.
Sun CQ; Zhong CY; Sun WW; Xiao H; Zhu P; Lin YZ; Zhang CL; Gao H; Song ZY
Sci Rep; 2016 Dec; 6():34929. PubMed ID: 27941821
[TBL] [Abstract][Full Text] [Related]
39. Tagging SNP haplotype analysis of the secretory PLA2-V gene, PLA2G5, shows strong association with LDL and oxLDL levels, suggesting functional distinction from sPLA2-IIA: results from the UDACS study.
Wootton PT; Arora NL; Drenos F; Thompson SR; Cooper JA; Stephens JW; Hurel SJ; Hurt-Camejo E; Wiklund O; Humphries SE; Talmud PJ
Hum Mol Genet; 2007 Jun; 16(12):1437-44. PubMed ID: 17545304
[TBL] [Abstract][Full Text] [Related]
40. Phospholipase A2 group IIA correlates with circulating high-density lipoprotein cholesterol and modulates cholesterol efflux possibly through regulation of PPAR-γ/LXR-α/ABCA1 in macrophages.
Liang L; Xie Q; Sun C; Wu Y; Zhang W; Li W
J Transl Med; 2021 Nov; 19(1):484. PubMed ID: 34838043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
